CAPE CANAVERAL, Fla. — Roughly nine months after its West Coast swan song, United Launch Alliance’s Delta IV Heavy rocket is preparing to do the same for the East Coast and the program all together.

ISLAMABAD: The federal government finds itself in a catch-22 over spectrum pricing, fearing that setting high prices could deter telecom operators, while lowering the prices — as recommended by a ...

Management raised Q4 2025 revenue guidance to $21.4 million to $22.4 million and GAAP diluted EPS guidance to $0.43 to $0.47, with non-GAAP diluted EPS of $0.47 to $0.50. For full year 2025, guidance ...

While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

Please provide your email address to receive an email when new articles are posted on . A 68-year-old man presented to an outside emergency department with 2 days of progressive bilateral eyelid ...

Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif., April 7, 2025 /PRNewswire/ -- ICU Medical Inc. (NASDAQ:ICUI), a worldwide ...

ICU Medical Inc, a worldwide leader in the development, manufacture and sale of innovative medical devices, has announced 510(k) regulatory clearance from the US Food and Drug Administration (FDA) for ...

ICU Medical, Inc. ICUI, yesterday, announced the FDA’s 510(k) clearance for the Plum Solo precision IV pump, a single-channel complement to the dual-channel Plum Duo. The company also received the 510 ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. With these FDA clearances, ICU Medical is introducing its new category of precision IV pumps and ...

The provincial cancer agency is halting its use of an infusion pump line, due to concerns over leakage and heightened risk of potentially hazardous chemotherapy drug spills. *No charge for 4 weeks ...

Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject of recalls — over concerns about leakage and the increased risk of ...